« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4
, Pages 313-319
, Winter 2005
Laser Ablation Therapies for Barrett’s Esophagus
References
- . Gastroesophageal reflux disease and Barrett’s oesophagus . Med Clin North Am . 2000;84:1137
- . The incidence of adenocarcinoma in Barrett’s esophagus (a prospective study of 170 patients followed 4.8 years) . Am J Gastroenterol . 1997;92(2):212–215
-
.
Esophageal cancer
.
New Engl J Med
. 2004;349:2241–2252
- . Barrett’s esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy . Ann Surg . 1996;224(1):66–71
- . Photodynamic therapy for Barrett’s esophagus (a review) . Dis Esophagus . 2002;15:137–144
- The history of photodetection and photodynamic therapy . Photochem Photobiol . 2001;74:656–669
- . Present status of photodynamic therapy for high grade dysplasia in Barrett’s esophagus . J Clin Gastroenterol . 2005;39:189–202
- . Photodynamic therapy for esophageal diseases (a clinical update) . Endoscopy . 2003;35:1059–1068
-
.
Non surgical management of Barrett’s esophagus with high grade dysplasia
.
Surg Oncol Clinic N Am
. 2002;11:321–326
- . Role of photodynamic therapy in the management of gastrointestinal cancer . Digestion . 1999;60:1–10
-
Photodynamic therapy
.
J Nat Cancer Inst
. 1998;90:889–905
-
.
Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract
.
Gastrointest Endosc Clin North Am
. 2000;10:513–532
- Optimization of the diameter of a radial irradiation device for photodynamic therapy in the esophagus . Endoscopy . 2002;34:411–415
- Photodynamic therapy of superficial esophageal cancer with a transparent hood . Gastrointest Endosc . 2004;60:120–124
- . Initial results using low-dose photodynamic therapy in the treatment of Barrett’s esophagus . Gastrointest Endosc . 1995;42(1):59–63
-
Controlled trial of low dose photodynamic therapy for Barrett’s esophagus
.
Gastroenterology
. 1997;112:A676
-
Photodynamic therapy
(results of curative intent for esophageal cancer and Barrett’s with high-grade dysplasia in high-risk patients)
.
Abstract.
International Biomedical Optics Symposium SPIE-The International Society for Optical Engineering
. 2000;
- . Photodynamic therapy for Barrett’s esophagus (follow-up in 100 patients) . Gastrointest Endosc . 1999;49(1):1–7
- . Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma (long-term results) . Gastrointest Endosc . 2003;58(2):183–188
- . Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract . Gastrointest Endosc Clin N Am . 2000;10(3):513–532
-
.
Photodynamic therapy for dysplastic Barrett’s esophagus and mucosal adenocarcinoma
.
[Abstract]
Gastrointest Endosc
. 2004;59:AB251
- Barrett’s esophagus after photodynamic therapy (risk of cancer development during long term follow up) . [Abstract] Gastroenterology . 2004;126(suppl 2):A50
- A multicenter partially blinded randomized study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high grade dysplasia (HGD) in Barrett’s esophagus (BE) (results of 6-month follow-up) . Gastroenterology . 2001;120:A79
- Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus (international, partially blinded, randomized phase III trial) . Gastrointest Endosc . 2005;62:488–498
- Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid . Gastroenterology . 1998;114(3):448–455
- Photodynamic therapy for dysplastic Barrett’s oesophagus (a prospective, double blind, randomised, placebo controlled trial) . Gut . 2000;47:612–617
- Comparison of high vs. low dose 5 aminolevulinic acid for photodynamic therapy of Barrett’s esophagus . Surg Endosc . 2004;18:452–458
- Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett’s esophagus? A pilot study . Endoscopy . 2002;34:611–616
- . Photodynamic therapy for oesophageal dysplasia and early carcinoma with mTHPC)m-tetrahydroxyphenyl chorin) (a preliminary study) . Lasers Med Sci . 2002;17:51–56
- Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett’s esophagus . J Gastrointest Surg . 2001;5(3):251–259
- Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole . Gastrointest Endosc . 2000;51(6):659–663
- Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ adenocarcinoma . Endoscopy . 2001;33(3):257–261
- . Argon Plasma Coagulation ablation of Barrett’s oesophagus . Scand J Gastroenterol . 2005;40:617–628
- Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus (factors determining persistence and recurrence of Barrett’s epithelium) . Gut . 2002;51(6):776–780
- Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression . Endoscopy . 2002;34(12):950–955
- Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression (immediate and mid term results) . Gut . 1998;43(6):747–751
- Endoscopic ablation of Barrett’s oesophagus (a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation) . Aliment Pharmacol Ther . 2004;20:1289–1296
- 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus (a randomized trial) . Gut . 2004;53:785–790
- KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett’s esophagus . Gastrointest Endosc . 1999;49:8–12
- . Cutaneous consequences of photodynamic therapy . Cutis . 2002;69:140–142
- Endoscopic photodynamic therapy for obstructing esophageal cancer (77 cases over a 2-year period) . Surg Endosc . 2000;14:653–657
- Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation . Am J Gastroenterol . 2000;95:2177–2184
- Optimization of light dosimetry for photodynamic therapy of Barrett’s esophagus (efficacy vs. incidence of stricture after treatment) . Gastrointest Endosc . 2005;61:13–18
- Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy . Gastroenterology . 2000;119:624–630
- Genomic analysis of Barretts esophagus after ablative therapy (Persistence of genetic alterations at tumor suppressor loci) . Int J Cancer . 2006;118:155–160
- Molecular evaluation of ablative therapy of Barrett’s oesophagus . J Pathol . 2005;205:57–64
- . Dysplasia in Barretts esophagus. Limitations of current management strategies . Am J Gastroenterol . 2005;100:927–935
- Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s esophagus . Gut . 2000;46:574–577
-
Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett’s esophagus
.
Am J Surg Path
. 2004;28:1466–1473
Drs. Pennathur and Abbas contributed equally to this article.
PII: S1043-0679(05)00084-5
doi: 10.1053/j.semtcvs.2005.10.004
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4
, Pages 313-319
, Winter 2005
